David Kirske is EVP, Chief Financial Officer of CTI BIOPHARMA CORP. Currently has a direct ownership of 0 shares of CTIC, which is worth approximately $0. The most recent transaction as insider was on Jul 01, 2020, when has been sold 3,798 shares (Common Stock) at a price of $0.98 per share, resulting in proceeds of $3,722. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

DAVID KIRSKE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2020
BUY
Grant, award, or other acquisition
$3,722 $0.98 p/Share
3,798 Added 50.0%
3,798 Common Stock
DK

David Kirske

EVP, Chief Financial Officer
Seattle, WA

Track Institutional and Insider Activities on CTIC

Follow CTI BIOPHARMA CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTIC shares.

Notify only if

Insider Trading

Get notified when an Cti Biopharma Corp insider buys or sells CTIC shares.

Notify only if

News

Receive news related to CTI BIOPHARMA CORP

Track Activities on CTIC